Search Result "Enzymatically-modified LDL"
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
Atherosclerosis-Related Functions of C-Reactive Protein
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 10 Issue: 4 Year: 2010 Page: 235-240
Author(s): Alok Agrawal, David J. Hammond, Sanjay K. Singh
Effect of Fenofibrate on the Concentration and Relative Distribution of LDL Subfractions in Patients with Combined Dyslipidemia
Journal: Letters in Drug Design & Discovery
Volume: 1 Issue: 4 Year: 2004 Page: 380-383
Author(s): V. Tsimihodimos, M. Elisaf, A. Tselepis, A. Tambaki, E. Bairaktari
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1021-1030
Author(s): Jan Nilsson, Gunilla Nordin Fredrikson, Alexandru Schiopu, Prediman K. Shah, Bo Jansson, Roland Carlsson
Possible Non-Classic Intracellular and Molecular Mechanisms of LDL Cholesterol Action Contributing to the Development and Progression of Atherosclerosis
Journal: Current Vascular Pharmacology
Volume: 2 Issue: 4 Year: 2004 Page: 363-370
Author(s): Ioanna Gouni-Berthold, Agapios Sachinidis
Oxidative Stress in Atherosclerosis Development: The Central Role of LDL and Oxidative Burst
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 351-360
Author(s): Ilaria Peluso,Giuseppa Morabito,Lourdes Urban,Francesca Ioannone,Mauro Serafi
Recent Advances on Detection of Modified Forms of Low-Density Lipoproteins
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3 Issue: 1 Year: 2009 Page: 28-34
Author(s): Tanize E.S. Faulin, Maria C.C. Garcia, Dulcineia S.P. Abdalla
Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6256-6269
Author(s): Constantinos C. Tellis, Alexandros D. Tselepis